Want to join the conversation?
Bill Schmitz of Deutsche Bank probes on the pricing in emerging markets lapping in 2H16. $PEP CFO Hugh Johnston said it's safe to assume that the company will continue to get good solid pricing in those markets. To the degree that the pricing is less, $PEP will see some volume bounce back.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?